InspireMD, Inc., a medical device company, focuses on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of vascular and coronary diseases in Europe, Latin America, the Middle East, and Asia. 1d
InspireMD Engages Hart Clinical Consultants to Conduct Clinical Trial for CGuard Carotid Stent System in the United States Tel Aviv, Israel – February 24, 2021 – InspireMD, Inc. (NYSE American: NSPR), developer of the CGuard™ Embolic Prevention System (EPS) for the prevention of stroke caused by carotid artery disease, announced today that it has engaged Hart...
NSPR InspireMD - Israeli Company with high volume, nice momentum ?? On the way to higher levels @ 5 $, @ 7 $, @ 11 $, @ 15 $ and above ?? Good luck and happy investing!
Now like you and many others I'm shocked by NSPR price action, so what could have caused it? Well theres one and that was the FDA IDE approval, yet today was ann that they got the full FDA IDE approval green light. News -Got FDA IDE approval in the US today -Last week they where at LD Micro 500 they gave us some company insights 1: Theres already sales in Brazil...
Okay I'm gonna start off with the news News -NSPR beat earnings by 44%, yet still losing money. It has been making more money due to its past performance and not losing as much. We can project that they might be profitable next year. -Their offering that was held in June came out that it was so they can remain compliant with the exchange. That Friday they have...
Now buying my 3000 shares than seeing it pump to .61 (highest RH showed), was just luck with getting the news about Brazil approval NSPR product, yet looking at the chart begs to wonder is it over? News -CGuard got approval to be used in Brazil. I will post a DD at the end of this for NSPR, yet the consumer market of CGuard in Brazil can be up too 213 million...
If you seen any of my other basic charts, you know I like wedges. Here I see another forming for NSPR. I don't always play these for mega pumps. I see this one eventually going to fill that GAP up north. I've been having some success with wedges, from my published ideas, 1 played out and 1 was a dud, 1 still to be seen? Either way I like wedges. Not finical...
Down Nearly 100 Percent From Alltime Highs I used log scale to view insane dump. Market Cap 1 point 8 million. If you buy now, you’ll be a millionaire! Great project. Buy asap!
I believe this stock can give from 3-20% in the next week. Long. Mother of longs and shorts, queen of the profits, Take care and get rich!
I wrote an extensive piece on NSPR in which I go into depth on the company and the potential turnaround story, you can find it here: rockvuecapital.wordpress.com Trading at a 77% discount to book value, an 81% discount to sales, an 81% discount to NCAV, and a 43% discount to net cash, NSPR is roadkill in the market. However, no matter how great the value may...
NSPR is trading in the middle of a rising wedge, so it has possibilities to trade long if the lower channel holds or to go short if you see a rejection on the upper channel. A strong rejection on the upper channel can determine a breakout to the downside.